Skip to content
CGTXCognition Therapeutics Inc

Earnings

When Cognition Therapeutics Inc reports, what it reported each quarter, and how the stock took the results.

27 quarters. Mar 31, 2020 to Sep 30, 2026. mixed units.

Next results · Q4 2026Projected

Mar 25, before the open

Thu, Mar 25, 2027in 128 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Mar 17 – Apr 2

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
—
Net income
-$3.34M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q3 2026-$4.15MNo Q3 2025 on file

Latest results

  1. Q3 2026Nov 5, 2026, before the openThe release7.0%by the close of Nov 5
    Revenue
    —
    —
    Net income
    -$4.15M
    N/M
    EPS
    -$0.04
    N/M
  2. Q2 2026Aug 6, 2026, after the closeThe release4.4%by the close of Aug 7
    Revenue
    —
    —
    Net income
    -$3.93M
    N/M
    EPS
    -$0.04
    N/M
  3. Q1 2026May 7, 2026, after the closeThe release+5.2%by the close of May 8
    Revenue
    —
    —
    Net income
    -$4.57M
    N/M
    EPS
    -$0.05
    N/M
  4. Q4 2025Mar 26, 2026, before the openThe release3.2%by the close of Mar 26
    Revenue
    —
    —
    Net income
    -$3.34M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 5, 2026 · pre-marketNov 5, 202636 d10-Q——-$0.047.0%
Q2 2026Jun 30, 2026Aug 6, 2026 · after-hoursAug 7, 202638 d10-Q——-$0.044.4%
Q1 2026Mar 31, 2026May 7, 2026 · after-hoursMay 8, 202638 d10-Q——-$0.05+5.2%
FY 2025
Q4 2025derivedDec 31, 2025Mar 26, 2026 · pre-marketMar 26, 202685 d10-K———3.2%
Q3 2025Sep 30, 2025Nov 6, 2025 · pre-marketNov 6, 202537 d10-Q——-$0.062.4%
Q2 2025Jun 30, 2025Aug 7, 2025 · after-hoursAug 7, 202538 d10-Q——-$0.11+10.7%
Q1 2025Mar 31, 2025May 7, 2025 · pre-marketMay 7, 202537 d10-Q——-$0.1415.6%
FY 2024
Q4 2024derivedDec 31, 2024Mar 20, 2025 · pre-marketMar 20, 202579 d10-K———4.6%
Q3 2024Sep 30, 2024Nov 13, 2024 · pre-marketNov 13, 202444 d10-Q——-$0.2510.3%
Q2 2024Jun 30, 2024Aug 8, 2024 · pre-marketAug 8, 202439 d10-Q——-$0.18—
Q1 2024Mar 31, 2024May 7, 2024 · pre-marketMay 7, 202437 d10-Q——-$0.27—
Earlier years, FY 2020 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 5, 2026122988
10-QAug 7, 2026092362
10-QMay 8, 2026057545
10-KMar 26, 2026034880
10-QNov 6, 2025107402
10-QAug 7, 2025010771
10-QMay 7, 2025006612
10-KMar 20, 2025003341
10-QNov 13, 2024015436
10-QAug 8, 2024011464

Provenance

ProvenanceData status and checks

Cognition Therapeutics Inc · CIK 1455365 · Engraved from SEC EDGAR